Abbonarsi

Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements - 18/08/11

Doi : 10.1016/j.ahj.2006.03.026 
Michael Lindstaedt, MD a, , Aydan Yazar, MD a, Alfried Germing, MD a, Markus K. Fritz, MD b, Tim Holland-Letz, MSC c, Andreas Mügge, MD a, Waldemar Bojara, MD a
a Medical Clinic II, University Hospital Bergmannsheil, Bochum, Germany 
b Division of Cardiothoracic Surgery, University Hospital Bergmannsheil, Bochum, Germany 
c Department of Medical Informatics, Biometry, and Epidemiology, Ruhr-University Bochum, Germany 

Reprint requests: Michael Lindstaedt, MD, Medizinische Klinik II, Universitätsklinik Bergmannsheil, Ruhr-Universität Bochum, Buerkle-de-la-Camp-Platz 1, 44789 Bochum, Germany.

Riassunto

Background

Correct assessment of the significance of left main stem lesions is of pivotal importance to the patient with coronary artery disease. On the basis of clinical and angiographic information alone, this evaluation often cannot be done reliably. Limited data suggest that coronary pressure-derived fractional flow reserve (FFR) supports decision making in equivocal left main disease.

Methods

All patients presenting to our institution between June 1999 and June 2004 with intermediate left main coronary artery disease (40%-80% diameter stenosis by angiography), or in whom left main coronary disease was suspected but could not be quantified angiographically, were included in this prospective single-center follow-up study. If FFR was <0.75 along the left main stem, surgical revascularization was recommended; if FFR was >0.80, medical treatment or percutaneous coronary intervention elsewhere in the coronary tree was chosen. If FFR was in the “gray zone,” between ≥0.75 and ≤0.80 treatment recommendation was dependent on additional individual criteria. Primary end points were freedom from death, myocardial infarction, any coronary revascularization procedure, and stroke.

Results

Fifty-one patients (mean age 62.2 ± 9.6 years, 41 male) were included. In 27 patients (53%), coronary artery bypass surgery was performed. The remaining 24 patients (47%) were treated nonsurgically. Mean follow-up was 29 ± 16 months. Estimated survival after 4 years of follow-up was 81% among patients in the surgical group and 100% among patients in the nonsurgical group. Event-free survival was 66% in the surgical group and 69% in the nonsurgical group.

Conclusions

Fractional flow reserve is helpful to identify patients with intermediate left main disease in whom deferral of surgical revascularization is associated with excellent survival and low event rates.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2006  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 152 - N° 1

P. 156.e1-156.e9 - luglio 2006 Ritorno al numero
Articolo precedente Articolo precedente
  • The effect of patient sex on recurrence of atrial fibrillation following successful direct current cardioversion
  • Osnat T. Gurevitz, Chitra J. Varadachari, Naser M. Ammash, Joseph F. Malouf, A. Gabriela Rosales, Regina M. Herges, Charles J. Bruce, Virend K. Somers, Stephen C. Hammill, Bernard J. Gersh, Paul A. Friedman
| Articolo seguente Articolo seguente
  • Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial
  • J. Emilio Exaire, Samuel M. Butman, Ramin Ebrahimi, Neal S. Kleiman, Robert A. Harrington, Marc J. Schweiger, John A. Bittl, Kathy Wolski, Eric J. Topol, A. Michael Lincoff, for the REPLACE-2 Investigators

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.